Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

NCT00095836 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Massachusetts General Hospital

Collaborators